BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang Y, Zhang H, Wang J, Liu Y, Luo T, Hua H. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J Hematol Oncol 2022;15:34. [PMID: 35331296 DOI: 10.1186/s13045-022-01252-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 31.0] [Reference Citation Analysis]
Number Citing Articles
1 Maihemuti A, Zhang H, Lin X, Wang Y, Xu Z, Zhang D, Jiang Q. 3D-printed fish gelatin scaffolds for cartilage tissue engineering. Bioact Mater 2023;26:77-87. [PMID: 36875052 DOI: 10.1016/j.bioactmat.2023.02.007] [Reference Citation Analysis]
2 Xie N, Xiao C, Shu Q, Cheng B, Wang Z, Xue R, Wen Z, Wang J, Shi H, Fan D, Liu N, Xu F. Cell response to mechanical microenvironment cues via Rho signaling: From mechanobiology to mechanomedicine. Acta Biomater 2023;159:1-20. [PMID: 36717048 DOI: 10.1016/j.actbio.2023.01.039] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Watterson A, Coelho MA. Cancer immune evasion through KRAS and PD-L1 and potential therapeutic interventions. Cell Commun Signal 2023;21:45. [PMID: 36864508 DOI: 10.1186/s12964-023-01063-x] [Reference Citation Analysis]
4 Essa A, Essa ES, El-deeb SM, Seleem HEM, Al Sahlawi M, Al-omair OA, Shehab-eldeen S. Elevated Serum Vinculin in Patients with HBV/HCV-Associated Liver Cirrhosis and Hepatocellular Carcinoma: A Pilot Study. BTT 2023;Volume 17:23-32. [DOI: 10.2147/btt.s405500] [Reference Citation Analysis]
5 Becconi M, De Zio S, Falciani F, Santamaria M, Malferrari M, Rapino S. Nano-Electrochemical Characterization of a 3D Bioprinted Cervical Tumor Model. Cancers (Basel) 2023;15. [PMID: 36831668 DOI: 10.3390/cancers15041327] [Reference Citation Analysis]
6 Shou Y, Teo XY, Li X, Zhicheng L, Liu L, Sun X, Jonhson W, Ding J, Lim CT, Tay A. Dynamic Magneto-Softening of 3D Hydrogel Reverses Malignant Transformation of Cancer Cells and Enhances Drug Efficacy. ACS Nano 2023;17:2851-67. [PMID: 36633150 DOI: 10.1021/acsnano.2c11278] [Reference Citation Analysis]
7 Jiang Y, Zhang H, Wang J, Chen J, Guo Z, Liu Y, Hua H. Exploiting RIG-I-like receptor pathway for cancer immunotherapy. J Hematol Oncol 2023;16:8. [PMID: 36755342 DOI: 10.1186/s13045-023-01405-9] [Reference Citation Analysis]
8 Khalilimeybodi A, Fraley SI, Rangamani P. Mechanisms underlying divergent relationships between Ca(2+) and YAP/TAZ signalling. J Physiol 2023;601:483-515. [PMID: 36463416 DOI: 10.1113/JP283966] [Reference Citation Analysis]
9 P.k. S, Banerjee A, Singh P. Promises and challenges for targeting the immunological players in the tumor micro-environment – Critical determinants for NP-based therapy. OpenNano 2023. [DOI: 10.1016/j.onano.2023.100134] [Reference Citation Analysis]
10 Zhang T, Hu R, Wang Y, Guo S, Wu Z, Liu J, Han C, Qiu C, Deng G. Extracellular matrix stiffness mediates uterine repair via the Rap1a/ARHGAP35/RhoA/F-actin/YAP axis. Cell Commun Signal 2023;21:22. [PMID: 36691027 DOI: 10.1186/s12964-022-01018-8] [Reference Citation Analysis]
11 Yang Z, Zhou Z, Si T, Zhou Z, Zhou L, Chin YR, Zhang L, Guan X, Yang M. High Throughput Confined Migration Microfluidic Device for Drug Screening. Small 2023;:e2207194. [PMID: 36634971 DOI: 10.1002/smll.202207194] [Reference Citation Analysis]
12 Mao BH, Nguyen Thi KM, Tang MJ, Kamm RD, Tu TY. The interface stiffness and topographic feature dictate interfacial invasiveness of cancer spheroids. Biofabrication 2023;15. [PMID: 36594698 DOI: 10.1088/1758-5090/acaa00] [Reference Citation Analysis]
13 Verma AH, Haldavnekar R, Venkatakrishnan K, Tan B. Dual-Purpose 3D-Silica Nanostructure Matrix for Rapid Epigenetic Reprogramming of Tumor Cell to Cancer Stem Cell Spheroid. Small Methods 2023;7:e2200798. [PMID: 36424183 DOI: 10.1002/smtd.202200798] [Reference Citation Analysis]
14 Mbugua SN. Targeting Tumor Microenvironment by Metal Peroxide Nanoparticles in Cancer Therapy. Bioinorg Chem Appl 2022;2022:5041399. [PMID: 36568636 DOI: 10.1155/2022/5041399] [Reference Citation Analysis]
15 Malta MD, Cerqueira MT, Marques AP. Extracellular matrix in skin diseases: The road to new therapies. J Adv Res 2022:S2090-1232(22)00264-8. [PMID: 36481476 DOI: 10.1016/j.jare.2022.11.008] [Reference Citation Analysis]
16 Cambi A, Ventre M. Collagen-Based Biomimetic Systems to Study the Biophysical Tumour Microenvironment. Cancers (Basel) 2022;14. [PMID: 36497421 DOI: 10.3390/cancers14235939] [Reference Citation Analysis]
17 Ghuloum FI, Johnson CA, Riobo-del Galdo NA, Amer MH. From mesenchymal niches to engineered in vitro model systems: Exploring and exploiting biomechanical regulation of vertebrate hedgehog signalling. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100502] [Reference Citation Analysis]
18 Li M, Zhao YY, Cui JF. Matrix stiffness in regulation of tumor angiogenesis. Shijie Huaren Xiaohua Zazhi 2022; 30(20): 871-878 [DOI: 10.11569/wcjd.v30.i20.871] [Reference Citation Analysis]
19 Chen X, Yuan Q, Liu J, Xia S, Shi X, Su Y, Wang Z, Li S, Shang D. Comprehensive characterization of extracellular matrix-related genes in PAAD identified a novel prognostic panel related to clinical outcomes and immune microenvironment: A silico analysis with in vivo and vitro validation. Front Immunol 2022;13:985911. [DOI: 10.3389/fimmu.2022.985911] [Reference Citation Analysis]
20 Bons J, Pan D, Shah S, Bai R, Chen-Tanyolac C, Wang X, Elliott DRF, Urisman A, O'Broin A, Basisty N, Rose J, Sangwan V, Camilleri-Broët S, Tankel J, Gascard P, Ferri L, Tlsty TD, Schilling B. Data-independent acquisition and quantification of extracellular matrix from human lung in chronic inflammation-associated carcinomas. Proteomics 2022;:e2200021. [PMID: 36228107 DOI: 10.1002/pmic.202200021] [Reference Citation Analysis]
21 Lee Y, Bae SJ, Eun NL, Ahn SG, Jeong J, Cha YJ. Correlation of Yes-Associated Protein 1 with Stroma Type and Tumor Stiffness in Hormone-Receptor Positive Breast Cancer. Cancers 2022;14:4971. [DOI: 10.3390/cancers14204971] [Reference Citation Analysis]
22 Khalilimeybodi A, Fraley S, Rangamani P. Mechanisms underlying divergent relationships between Ca2+ and YAP/TAZ signaling.. [DOI: 10.1101/2022.10.06.511161] [Reference Citation Analysis]
23 Swamy K. Vascular normalization and immunotherapy: Spawning a virtuous cycle. Front Oncol 2022;12:1002957. [DOI: 10.3389/fonc.2022.1002957] [Reference Citation Analysis]
24 Chen J, Zhang Z, Li Y, Zeng H, Li Z, Wang C, Xu C, Deng Q, Wang Q, Yang X, Li Z. Precise fibrin decomposition and tumor mechanics modulation with hydroxyethyl starch-based smart nanomedicine for enhanced antitumor efficacy. J Mater Chem B 2022. [PMID: 36172808 DOI: 10.1039/d2tb01812h] [Reference Citation Analysis]
25 Dekker Y, Le Dévédec SE, Danen EHJ, Liu Q. Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer. Genes (Basel) 2022;13:1585. [PMID: 36140753 DOI: 10.3390/genes13091585] [Reference Citation Analysis]
26 Firnau M, Brieger A. CK2 and the Hallmarks of Cancer. Biomedicines 2022;10:1987. [DOI: 10.3390/biomedicines10081987] [Reference Citation Analysis]
27 Zhu K, Wu Y, He P, Fan Y, Zhong X, Zheng H, Luo T. PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer. Cells 2022;11:2508. [PMID: 36010585 DOI: 10.3390/cells11162508] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Bons J, Pan D, Shah S, Bai R, Chen-tanyolac C, Wang X, Fels Elliott DR, Urisman A, O’broin A, Basisty N, Rose J, Sangwan V, Camilleri-broët S, Tankel J, Gascard P, Ferri L, Tlsty TD, Schilling B. Data-Independent Acquisition and Quantification of Extracellular Matrix from Human Lung in Chronic Inflammation-Associated Carcinomas.. [DOI: 10.1101/2022.08.05.503012] [Reference Citation Analysis]
29 Lam KH, Ma S. Noncellular components in the liver cancer stem cell niche: Biology and potential clinical implications. Hepatology 2022. [PMID: 35727189 DOI: 10.1002/hep.32629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
30 Yan H, Zhai B, Yang F, Chen Z, Zhou Q, Paiva-Santos AC, Yuan Z, Zhou Y. Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma. Front Pharmacol 2022;13:908713. [PMID: 35721107 DOI: 10.3389/fphar.2022.908713] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 González-novo R, de Lope-planelles A, González-murillo Á, Madrazo E, Acitores D, de Lacoba MG, Ramírez M, Redondo-muñoz J. Targeting H3K4 methylation as a novel therapeutic strategy against tumor infiltration and nuclear changes of acute lymphoblastic leukemia cells.. [DOI: 10.1101/2022.06.16.495903] [Reference Citation Analysis]